Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
REDWOOD CITY, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that Laurent Fischer, MD, President and Chief Executive Officer, and Szilárd K...
Could the fireside chat raise the visibility of ADVM among analysts and potentially lead to coverage upgrades?
Might the management commentary address competitive positioning versus rivals like Astellas, Novartis, or Roche?
How does this conference align with Adverum's long‑term strategic milestones and product launch timelines?
21 days ago